Statistics for vTv Therapeutics (id:5687 VTVT)

Valuation metrics

Market cap

45.45M

Enterprise value

-7,531,959.00

Trailing P/E (ttm)

-1.46

Forward P/E

-52.73

PEG ratio

-52.73

Price/Sales (ttm)

45.45

Price/Book (mrq)

4.44

Enterprise Value/Revenue

-7.53

Enterprise Value/EBITDA

0.33

Overview

Shares outstanding

2.43M

Float

883.71K

Shares short

28.85K

% Held by insiders

0.39%

% Held by institutions

0.15%

Average volume (10 days)

65.25K

Average volume (90 days)

Price summary

52-Week low

7.38

52-Week high

30.99

52-Week change

32.23%

Beta

0.63

50-Day moving average

14.23

200-Day moving average

18.08

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 21th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,285.70%

Operational effectiveness

Return on assets

-41.48%

Return on equity

-362.13%

Income statement

Revenue (ttm)

0.41

Revenue per share (ttm)

0.41

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-22,767,000.00

Net income to common (ttm)

-20,177,000.00

Diluted EPS (ttm)

-6.83

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

45.59M

Total cash per share (mrq)

18.74

Total debt (mrq)

256.00K

Total Debt/Equity (mrq)

1.25

Current ratio (mrq)

661.40%

Book value per share (mrq)

-11.84

Cash flow

Cash flow statement

-21,812,000.00

Levered free cash flow (LFCF)

-13,889,500.00